All timings shown are UK BST
.jpg?ext=.jpg){kind=logo}
John has a strong background and reputation in the European e-cigarette industry having held senior executive positions in some of the US and Europe’s biggest companies. As managing director of Dyflin Group Consulting, he advises many leading industry analysts, financial institutions and media organisations looking at the vaping sector. John is also Director-General and one of the founders of the UKVIA, the UK’s largest vaping Industry association and has advised the UK government All Party Parliamentary Group on Vaping as well as giving evidence before the UK Science & Technology Committee investigation into the Vaping industry, the Australian and Irish Parliaments review on vaping. John regularly appears on national television, radio as well as national and international print media. John is a popular guest speaker at many of the world’s leading conventions.
Tim Phillips is managing director of ECigIntelligence, the leading source of independent data for the e-cigarette and vaping sector globally, providing unbiased information to numerous leading international companies together with government regulators such as the FDA and the UK government. He is also managing director of a sister publication, CBD-Intel, which is a business intelligence service providing professional, independent market analysis and regulatory tracking for the growing cannabidiol sectors worldwide.
He is a U.K.-qualified attorney, having worked at the European Commission, Herbert Smith, BSkyB, AOL Europe, and as director of public affairs at Betfair as it went through its £1.5bn IPO in 2010. He was also a partner in a New York venture capital-funded startup in the diamond sector. Phillips qualified as a lawyer at the College of Law, London, and holds an MA in Geology from Oxford University.
Over 30 years’ industry experience both in research & development, regulatory preclinical work & toxicological risk assessment. Director of preclinical toxicology & pharmacology at a CRO for 13 years. Senior Toxicologist/Toxicology Manager at several FMCG companies under the Product Stewardship department, supporting the next Generation Products by advising the company on the Quantitative Risk Assessment procedure under current regulations, the testing strategy for innovative products to ensure their safe commercialization, liaising with external advisors, engaging with regulators & communicating & presenting projects/strategies to internal stakeholders.
Thorough understanding & knowledge of the regulatory pre-requisites for preclinical testing, having put together many preclinical study packages for a large diversity of pharmaceutical compounds with diverse routes of administration & applications (inflammation, pulmonary, gastrointestinal, CNS, etc), including biotechnology-derived products & advanced therapies such as cellular therapy & genetic therapy products, as well as consumer products (oral & inhalation). Carried out toxicological risk-assessment & exposure evaluations for numerous consumer products, including specific assessments of food additives, flavourings & chemicals according to ECHA REACH Technical Guidance. Acted as Expert Advisor to the EC on the 7th Framework Program (FP7), as well as presently under the Eurostars (EUREKA) programme.
Nigel R Quine
Founder of Cuts Ice Limited.
Co-Founder of Flavour Core Limited.
Co-Founder of IBVTA (Independent British Vape Trade Association).
Co-Founder of IEVA (Independent European Vape Alliance).
10 years working in the vape industry, developing standards and a sensible regulatory framework for the sector.
Pioneering the development of ‘vape grade’ products and the safety of flavours in ENDS.
Investor in the independent vape channel, promoting specialist retail as the most effective provider of smoking cessation services which keep smokers off harmful combustible products.